Board of the College of Pharmacists of British Columbia Regulation

B.C. Reg. 236/2023: Amendments to the Drug Schedules Regulation

Made under the Pharmacy Operations and Drug Scheduling Act

How does this rule affect your organization? One Click reads it against your profile and tells you, on Canada Federal Legislative Tracking. See plans →

Get alerted when the next rule lands

New rules land on their own schedule. Pick how you want to hear about them — we email you when one appears.

Publishing to members? Embed a live rule tracker on your own site — the proposed rules in your area and the comment deadlines closing on them, updating themselves. Free, one line of HTML.

The rule, in full

184 words as published, December 05, 2023. View the original →

B.C. Reg. 236/2023, deposited November 20, 2023, under the PHARMACY OPERATIONS AND DRUG SCHEDULING ACT [section 22]. Resolution of the Board of the College of Pharmacists of British Columbia, dated October 13, 2023. The Board of the College of Pharmacists of British Columbia orders that the Drug Schedules Regulation, B.C. Reg. 9/98, is amended as set out in the attached Appendix. — S. SOLVEN, Chair, Board of the College of Pharmacists of British Columbia.

Appendix

1 The Schedules to the Drug Schedules Regulation, B.C. Reg. 9/98, are amended (a) by adding the following: 1 Azelastine and its salts 1 Bepotastine and its salts or derivatives 1 Besifloxacin and its salts 1 Efinaconazole 3 Loratidine and its salts and preparations in products labelled for use in children aged 2 to 11 years, in package sizes containing greater than 140 mg of loratadine 1 Ozenoxacin and its salts 1 Rupatadine and its salts 1 Trifarotene and its salts , and (b) by striking out the following: 3 Loratidine and its salts and preparations in products marketed for pediatric use (under 12 years of age) .